Nectar Lifesciences Balans Gezondheid
Financiële gezondheid criteriumcontroles 4/6
Nectar Lifesciences heeft een totaal eigen vermogen van ₹10.8B en een totale schuld van ₹6.3B, wat de schuld-eigenvermogensverhouding op 58.4% brengt. De totale activa en totale passiva bedragen respectievelijk ₹21.8B en ₹11.1B. De EBIT Nectar Lifesciences is ₹1.1B waardoor de rentedekking 1.4 is. Het heeft contanten en kortetermijnbeleggingen van ₹187.3M.
Belangrijke informatie
58.4%
Verhouding schuld/eigen vermogen
₹6.29b
Schuld
| Rente dekkingsratio | 1.4x |
| Contant | ₹187.35m |
| Aandelen | ₹10.78b |
| Totaal verplichtingen | ₹11.05b |
| Totaal activa | ₹21.83b |
Recente financiële gezondheidsupdates
Here's Why Nectar Lifesciences (NSE:NECLIFE) Has A Meaningful Debt Burden
Jul 27
Does Nectar Lifesciences (NSE:NECLIFE) Have A Healthy Balance Sheet?
Dec 22Nectar Lifesciences (NSE:NECLIFE) Has Debt But No Earnings; Should You Worry?
Jun 16Nectar Lifesciences (NSE:NECLIFE) Takes On Some Risk With Its Use Of Debt
Jun 21Nectar Lifesciences (NSE:NECLIFE) Takes On Some Risk With Its Use Of Debt
Jul 29Nectar Lifesciences (NSE:NECLIFE) Has A Somewhat Strained Balance Sheet
Jan 21Recent updates
Revenues Working Against Nectar Lifesciences Limited's (NSE:NECLIFE) Share Price Following 26% Dive
Oct 11Nectar Lifesciences Limited (NSE:NECLIFE) Shares Fly 31% But Investors Aren't Buying For Growth
Aug 22Here's Why Nectar Lifesciences (NSE:NECLIFE) Has A Meaningful Debt Burden
Jul 27Nectar Lifesciences Limited (NSE:NECLIFE) Stock Catapults 27% Though Its Price And Business Still Lag The Industry
Feb 19Does Nectar Lifesciences (NSE:NECLIFE) Have A Healthy Balance Sheet?
Dec 22Nectar Lifesciences (NSE:NECLIFE) Has Debt But No Earnings; Should You Worry?
Jun 16Nectar Lifesciences (NSE:NECLIFE) Takes On Some Risk With Its Use Of Debt
Jun 21Nectar Lifesciences (NSE:NECLIFE) Takes On Some Risk With Its Use Of Debt
Jul 29Is Nectar Lifesciences Limited (NSE:NECLIFE) A Risky Dividend Stock?
Feb 25Nectar Lifesciences (NSE:NECLIFE) Has A Somewhat Strained Balance Sheet
Jan 21Zooming in on NSE:NECLIFE's 0.3% Dividend Yield
Nov 02Does Nectar Lifesciences (NSE:NECLIFE) Have A Healthy Balance Sheet?
Sep 07
If You Had Bought Nectar Lifesciences (NSE:NECLIFE) Stock A Year Ago, You Could Pocket A 47% Gain Today
Aug 09The Nectar Lifesciences (NSE:NECLIFE) Share Price Has Gained 47% And Shareholders Are Hoping For More
Aug 09What You Can Learn From Nectar Lifesciences Limited's (NSE:NECLIFE) P/E
Jul 13Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( ₹13.1B ) NECLIFE } overtreffen de korte termijn passiva ( ₹10.0B ).
Langlopende schulden: De kortetermijnactiva NECLIFE ( ₹13.1B ) overtreffen de langetermijnschulden ( ₹1.1B ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: De netto schuld/eigen vermogen ratio ( 56.6% ) NECLIFE wordt als hoog beschouwd.
Schuld verminderen: De schuld/eigen vermogen-ratio van NECLIFE is de afgelopen 5 jaar gedaald van 78.1% naar 58.4%.
Schuldendekking: De schuld van NECLIFE wordt goed gedekt door de operationele kasstroom ( 25.2% ).
Rentedekking: De rentebetalingen van NECLIFE op haar schulden worden niet goed gedekt door EBIT ( 1.4 x dekking).